"We launch coverage of GE Aerospace with an Outperform rating, target price $201."
(ELF) with a Buy rating and a 12-month price target of $175 per share."
"We initiate with a Buy rating on Harmony , a commercial stage biotech focused on CNS [central nervous system] disorders."
"We are initiating coverage of ProKidney Corp. (PROK) with a BUY rating and $6 price target."
We are initiating coverage with a BUY rating and $600 price target."
Persons:
Morgan Stanley, Apple, Tesla, it's, Bernstein, Riley, Wolfe, Stryker, BUD, JMP, Redburn, BTIG, Palantir, Goldman Sachs, Nutrien, Goldman, Cantor Fitzgerald, Cantor, Melius, Johnson, Guggenheim, it's bullish, D.A, Davidson, Meta
Organizations:
Apple, Apple Intelligence, Intelligence, Deutsche Bank, Deutsche, GE Aerospace, GE, Inc, Anheuser, Busch InBev, Oracle, Costco, Equity, Haemonetics, Plasma Solutions, Blood Center, Hospital Care Solutions, " Bank of America, Bank of America, UBS, Amazon, Harmony Biosciences, NTR, Nvidia, Broadcom, Johnson, Johnson Controls, ProKidney Corp